DARPA (the US military's advanced research agency) signed a contract with a company called NRx to explore combining a drug treatment with TMS (transcranial magnetic stimulation — a device that uses magnetic pulses to stimulate the brain). This is good news for NRx specifically, but it won't lift the stock prices or fortunes of other psychedelic companies like CMPS, ATAI, or MMED. Government contracts are narrow and targeted.
Consensus of 3 agents: investor, journalist, fda_reviewer. 0 dissenting.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →